1-13 of 13
tp53 gene
Close
Sort by
Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.
https://doi.org/10.1182/hematology.2019000011
Published: 2019
Journal Articles

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

Gregory W. Roloff, Elizabeth A. Griffiths
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 35–44.
https://doi.org/10.1182/asheducation-2018.1.35
Published: 2018
Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.
https://doi.org/10.1182/asheducation-2017.1.329
Published: 2017
Journal Articles

How should we sequence and combine novel therapies in CLL?

Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 346–353.
https://doi.org/10.1182/asheducation-2017.1.346
Published: 2017
Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.
https://doi.org/10.1182/asheducation-2017.1.338
Published: 2017
Journal Articles

Sequencing of chronic lymphocytic leukemia therapies

Jacqueline C. Barrientos
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 128–136.
https://doi.org/10.1182/asheducation-2016.1.128
Published: 2016
Journal Articles

Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?

Michael Heuser
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 24–32.
https://doi.org/10.1182/asheducation-2016.1.24
Published: 2016
Journal Articles

Prognostication of chronic lymphocytic leukemia in the era of new agents

Barbara Eichhorst, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 149–155.
https://doi.org/10.1182/asheducation-2016.1.149
Published: 2016
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Management of prolymphocytic leukemia

Claire Dearden
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.
https://doi.org/10.1182/asheducation-2015.1.361
Published: 2015
Journal Articles

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1 , SF3B1 , and TP53

Clive S. Zent, W. Richard Burack
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 119–124.
https://doi.org/10.1182/asheducation-2014.1.119
Published: 2014
Journal Articles

Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia

Stephan Stilgenbauer, Thorsten Zenz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 481–488.
https://doi.org/10.1182/asheducation-2010.1.481
Published: 2010
Journal Articles

Biology and Management of Histologic Transformation of Indolent Lymphoma

Arnold S. Freedman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 314–320.
https://doi.org/10.1182/asheducation-2005.1.314
Published: 2005